CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 58 target
Drug / intervention
Radiofrequency non ablativedevice
Likely dose
Not stated in record
Key inclusion· 3
  • Women in menopause up to 65 years old
  • Clinical complaints of Genitourinary Syndrome of Menopause
  • Voluntary participation in research
Key exclusion· 6
  • Limited understanding (cognitive impairment)
  • Neurological degenerative chronic diseases
  • Sensory deficit in genital region
  • Pacemaker users

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03506594
NCT03506594N/ARecruitingUpdate OverdueUpdated 25mo ago · Completion was 6mo ago
Enrollment Stalled
Long Recruiting
Update Overdue

Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Centro de Atenção ao Assoalho Pélvico·interventional·Posted Apr 24, 2018·Updated May 29, 2024

In Brief

A clinical study evaluating Radiofrequency non ablative for Genitourinary Syndrome of Menopause. Currently recruiting, targeting 58 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

The study is conducted in women at the menopause with a clinical diagnosis of Genitourinary Syndrome, which presents symptoms in of vulvovaginal atrophy and tract urinary and were treated with radiofrequency non ablative technique for capacitive transfer in intra-vaginal. All participants were evaluated by a physical therapist and did the exam of PH vaginal, cell maturation index and questionnaires. The participants made five sessions of Radio Frequency (RF) with an interval of seven days between them. The application of RF was performed by physical therapist trained in the technique of radio frequency through the Capenergie brand device with capacitive transfer method using non-ablative handle with active electrode intra-vaginal and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration above 20 minutes. The temperature was measured by an infrared thermometer when it reached 41graus radiofrequency was maintained for 2 minutes in the anterior wall and 2 minutes more in the posterior wall of vagina.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

N/ARecruitingOverdue
20192020202120222023202420252026
First PostedApr 24, 2018
Enrollment StartApr 1, 2018
Primary CompletionDec 1, 2025
Study CompletionJun 20, 2026
TodayJul 2, 2026
Enrollment to primary: 7.7 yearsPosted 8.2 years ago

Interventions

Radiofrequency non ablativedevice

The application of RF was performed by physical therapist trained in the technique of radiofrequency through the CAPENERGY device with capacitive transfer method using non-ablative handle with active electrode placed intra-vaginal and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration above 20 minutes. The temperature was measured by an infrared thermometer and when it reached 41°C radiofrequency was maintained for 2 minutes in the anterior wall and 2 other minutes in the posterior wall of the vagina.